These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 14527240)

  • 1. Pharmaceutical promotion, advertising, and consumers.
    Batchlor E; Laouri M
    Health Aff (Millwood); 2003; Suppl Web Exclusives():W3-109-11. PubMed ID: 14527240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advertising and prescription drugs: promotion, education, and the public's health.
    Avorn J
    Health Aff (Millwood); 2003; Suppl Web Exclusives():W3-104-8. PubMed ID: 14527239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two advertisements for TV drug ads.
    Bodenheimer T
    Health Aff (Millwood); 2003; Suppl Web Exclusives():W3-112-5. PubMed ID: 14527241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What do we know about direct-to-consumer advertising of prescription drugs?
    Calfee JE
    Health Aff (Millwood); 2003; Suppl Web Exclusives():W3-116-9. PubMed ID: 14527242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consumers' reports on the health effects of direct-to-consumer drug advertising.
    Weissman JS; Blumenthal D; Silk AJ; Zapert K; Newman M; Leitman R
    Health Aff (Millwood); 2003; Suppl Web Exclusives():W3-82-95. PubMed ID: 14527237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prescription drug advertising: is it a driving force on drug pricing?
    Millstein LG
    N C Med J; 2003; 64(6):289-91. PubMed ID: 14983621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct-to-consumer marketing of prescription drugs: creating consumer demand.
    Hollon MF
    JAMA; 1999 Jan; 281(4):382-4. PubMed ID: 9929096
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmaceutical promotion: don't throw the baby out with the bathwater.
    Dubois RW
    Health Aff (Millwood); 2003; Suppl Web Exclusives():W3-96-103. PubMed ID: 14527238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 3-stage model for assessing the probable economic effects of direct-to-consumer advertising of pharmaceuticals.
    Vogel RJ; Ramachandran S; Zachry WM
    Clin Ther; 2003 Jan; 25(1):309-29. PubMed ID: 12637129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examining the FDA's oversight of direct-to-consumer advertising.
    Gahart MT; Duhamel LM; Dievler A; Price R
    Health Aff (Millwood); 2003; Suppl Web Exclusives():W3-120-3. PubMed ID: 14527243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicalization, markets and consumers.
    Conrad P; Leiter V
    J Health Soc Behav; 2004; 45 Suppl():158-76. PubMed ID: 15779472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefit and risk information in prescription drug advertising: review of empirical studies and marketing implications.
    Kopp SW; Bang HK
    Health Mark Q; 2000; 17(3):39-56. PubMed ID: 11010219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viewpoint: the business of pharmaceuticals. Interview by Richard Service and Helen Lippman.
    Markham R
    State Health Care Am; 2001; ():22-3. PubMed ID: 11550658
    [No Abstract]   [Full Text] [Related]  

  • 14. The influences of drug companies' advertising programs on physicians.
    Güldal D; Semin S
    Int J Health Serv; 2000; 30(3):585-95. PubMed ID: 11109183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do drug company promotions influence physician behavior?
    Goodman B
    West J Med; 2001 Apr; 174(4):232-3. PubMed ID: 11290664
    [No Abstract]   [Full Text] [Related]  

  • 16. Direct marketing of pharmaceuticals to consumers.
    Lyles A
    Annu Rev Public Health; 2002; 23():73-91. PubMed ID: 11910055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The price of seduction: direct-to-consumer advertising of prescription drugs in the US.
    Marks JH
    N C Med J; 2003; 64(6):292-5. PubMed ID: 14983622
    [No Abstract]   [Full Text] [Related]  

  • 18. Direct-to-consumer promotion of prescription drugs. Economic implications for patients, payers and providers.
    Findlay SD
    Pharmacoeconomics; 2001; 19(2):109-19. PubMed ID: 11284378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marketplace. Managed care plans try to cope as drug ads spur patient demand.
    Moskowitz DB
    Med Health; 1998 May; 52(20):suppl 1-2. PubMed ID: 10179010
    [No Abstract]   [Full Text] [Related]  

  • 20. The rising utilization and costs of prescription drugs.
    PHC4 FYI; 2004; (26):1-2. PubMed ID: 15344277
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.